Berlin Metropolitan Area
Results-driven senior leader in the LifeScience industry with proven track record in Digital Strategy (discovery, development, regulatory, quality, medical and safety). Sound scientific (oncology, biochemistry, molecular biology, neuroscience), technology (enterprise architecture, data architecture and governance, product portfolio management), and professional leadership experience. Key strengths in analytical thinking, creativity, managing ambiguity and outcome focused execution. Proven track record in turnaround of legacy organizations through strategic positioning, professional innovation and relationship management. I am used to steering large investment portfolios with full accountability and reliable execution of projects delivering ROI while addressing company needs and promoting growth. I am experienced in leading multi-disciplinary, multi-national units of organizations and complex projects incl. strategy execution, organizational and business process redesign and disintegrations across the entire value chain from R&D, pharmaceutical logistics and strategic sourcing. I am passionate to build, lead and transform organizations strategically in innovative fields with a focus on delivering value. I enjoy shaping high-performance organizations and top talents across cultures and geographies.
Responsible and leading development of key assets in thrombosis with incredible and highly engaged teams with a strong cross-disciplinary product mindset. Cross-disciplinary responsibility across preclinical pharmacology, preclinical safety, early clinical development, CMC, clinical development, clinical operations, regulatory and safety. Responsible to lead integrated product development portfolio in close cooperation with Access, Marketing and Commercial expert functions.
Responsible for the successful clinical development and operations of Cell and Gene Therapies of - the assets of Bayer's independent Biotech research platform companies BlueRock in neurological indications in cell therapy (Parkinson's and inherited retinal disease) and AskBio for neuromuscular indications in GeneTherapy (Congestive Heart Failure, Parkinson's, Limb-Girdle Muscular Dystrophy and more). - transforming clinical trial design towards agility and product orientation And the setup of an organization for strategic workforce development (Learning and Training) that meets the ambitious goals of the entire R&D organization.
Postdoctoral researcher and project leader with employee leadership responsibility
PhD, international research project in Neusoscience in collaboration of with the Yale University, New Haven (USA)